(
PDF)
Werner Zolg, Head R&D Marker Discovery, New Reagents
Systems, Penzberg
Therapies that promise to make a difference
(
PDF)
Urs Schleuniger, Business Director Hematology and Autoimmune
Diseases, Basel
Progress in the therapy of Rheumatoid Arthritis
(
PDF)
Marc Feldman, Professor
at the Kennedy Institute of Rheumatology Division, Faculty of Medicine, Imperial College, London